Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality
Author(s) -
Richard M. Martin,
Jenny Donovan,
Emma L. Turner,
Chris Metcalfe,
Grace Young,
Eleanor Walsh,
J. Athene Lane,
Sian Noble,
Steven Oliver,
Simon Evans,
Jonathan A C Sterne,
Peter Holding,
Yoav BenShlomo,
Peter Brindle,
Naomi Williams,
Elizabeth Hill,
Siaw Yein Ng,
Jessica Toole,
Marta Tazewell,
Laura J. Hughes,
Charlotte Davies,
Joanna Thorn,
Liz Down,
George Davey Smith,
David E. Neal,
Freddie C. Hamdy
Publication year - 2018
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2018.0154
Subject(s) - medicine , prostate cancer , randomization , prostate specific antigen , randomized controlled trial , cancer , prostate cancer screening , stage (stratigraphy) , gynecology , oncology , paleontology , biology
Prostate cancer screening remains controversial because potential mortality or quality-of-life benefits may be outweighed by harms from overdetection and overtreatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom